Home > Analytics > MANGALAM DRUGS AND ORGANICS

MANGALAM DRUGS AND ORGANICS
Intrinsic Value | Fundamental Analysis

BOM : 532637     NSE : MANGALAM    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Dec 04,2024
Price(EOD): ₹ 122.80
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 194.02 Cr
Value of ₹ 1 Lac invested in MANGALAM DRUGS AND ORGANICS
on Dec 04,2019 (price: ₹ 28.55)

₹ 1 L

₹ 4.30 L

1W : 14.7% 1M : 10.4% 1Y : 22.7%
COMMUNITY POLL
for MANGALAM DRUGS AND ORGANICS
Please provide your vote to see the results
MANGALAM DRUGS AND ORGANICS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
MANGALAM DRUGS AND ORGANICS 14.7% 10.4% 22.7%
SUN PHARMACEUTICAL INDUSTRIES 3.7% -3.2% 46.6%
CIPLA 0.6% -3.7% 26.7%
DR REDDYS LABORATORIES 1.9% -3.4% 5.8%
ZYDUS LIFESCIENCES 2.3% -3.4% 54%
DIVIS LABORATORIES 5.1% 6.1% 64%
MANKIND PHARMA 1.3% -3.5% 35.8%
TORRENT PHARMACEUTICALS 4.6% 4.4% 58%
LUPIN 5.1% -4.4% 62.5%

FUNDAMENTAL ANALYSIS OF MANGALAM DRUGS AND ORGANICS

 
Fundamentals Score
[ Q(TTM): Sep2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF MANGALAM DRUGS AND ORGANICS

 
Valuation Score
[As on : Dec 04,2024 ]

Ratio Standalone
P/E
P/B
P/S
20.64
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 9.42 Cr
[Latest Qtr - Sep2024 - Standalone Results ]

1.37
P/B Calculated based on Book Value of Rs 142.35 Cr
[Latest Year - Mar2024 - Standalone Results ]

0.55
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 9% undervalued companies ! Discover More →

FAIR VALUE OF MANGALAM DRUGS AND ORGANICS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
34%
12%
30%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF MANGALAM DRUGS AND ORGANICS


Insights 💡 MANGALAM is one of the top 32% companies with bullish price momentum currently! Discover More →

MANGALAM DRUGS AND ORGANICS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF MANGALAM DRUGS AND ORGANICS

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.67
0.49
0.52
0.56
-
-
-
-
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF MANGALAM DRUGS AND ORGANICS

Pledged Promoter Shares
18.08 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF MANGALAM DRUGS AND ORGANICS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
4.45%
6.18%
103.93%
-0.04%
-1.98%
296.58%
125.14%
175.42%
QtrlyTrend
4
Latest Qtr: Sep2024
Quarterly Result Analysis →


MANGALAM DRUGS AND ORGANICS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about MANGALAM DRUGS AND ORGANICS


Is MANGALAM DRUGS AND ORGANICS good for long term investment?

As on Dec 04,2024, the Fundamentals of MANGALAM DRUGS AND ORGANICS look Poor and hence it may not be good for long term investment ! See Financial Performance of MANGALAM DRUGS AND ORGANICS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is MANGALAM DRUGS AND ORGANICS UnderValued or OverValued?

As on Dec 04,2024, MANGALAM DRUGS AND ORGANICS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of MANGALAM DRUGS AND ORGANICS ?

As on Dec 04,2024, the Intrinsic Value of MANGALAM DRUGS AND ORGANICS is Rs. 94.64 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 91.97
Fair Value [Median EV / Sales Model] : Rs. 109.29
Fair Value [Median Price / Sales Model] : Rs. 94.64
Estimated Median Fair Value of MANGALAM DRUGS AND ORGANICS : Rs. 94.64

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is MANGALAM DRUGS AND ORGANICS trading at a Premium or Discount?

As on Dec 04,2024, MANGALAM DRUGS AND ORGANICS is trading at a Premium of 30% based on the estimates of Median Intrinsic Value!